510(k) K262043

MEDRAD® MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD® IS12 Module (IS12); MEDRAD® Imaging Bulk Package Transfer Spike by Bayer Medical Care, Inc. — Product Code DXT

K262043 is an FDA 510(k) premarket notification submitted by Bayer Medical Care, Inc. for the device "MEDRAD® MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD® IS12 Module (IS12); MEDRAD® Imaging Bulk Package Transfer Spike". The FDA issued a decision of Substantially Equivalent on Oct 6, 2026. The device falls under product code DXT (Injector And Syringe, Angiographic), a Class II device regulated under 21 CFR 870.1650. Bayer Medical Care, Inc. has 10 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 6, 2026
Date Received
Jun 17, 2026
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Injector And Syringe, Angiographic
Device Class
Class II
Regulation Number
870.1650
Review Panel
HO
Submission Type
510(k)

Source: FDA 510(k) database entry for K262043. Report a data issue: hello@regdatalab.com.